The role of cholecystokinin octapeptide in the central control of food intake in the dog

Peptides. 1987 Jul-Aug;8(4):651-6. doi: 10.1016/0196-9781(87)90040-4.

Abstract

Cholecystokinin octapeptide (CCK-8, 1, 190 pmol/5 min) decreased food intake and water consumption in two models of ingestive behavior, i.e., food deprivation-induced feeding and insulin-induced feeding, when administered into the third (3V) and lateral (LV) cerebral ventricles. In fasted dogs, the suppression of food intake was more prominent after 3V CCK-8, whereas intravenously administered CCK-8 was without effect. Neuropeptide Y (NPY, 1, 190 pmol) had no significant stimulatory effect on food intake and water consumption in fasted as well as satiated dogs, and actually reduced both food and water intake in insulin-treated dogs. There was a slight but significant decrease in food and water intake after 275 nmol naloxone administration in both feeding models, and some of the dogs vomited. In insulin-treated animals, CCK-8 reversed, but NPY potentiated the hypothermic phase of temperature response observed after saline administration, whereas naloxone failed to alter rectal temperature. These results suggest that the effect of CCK-8 on feeding seems to involve central mechanisms in the dog, and that the mechanisms by which CCK-8, NPY and naloxone affect feeding behavior are different.

MeSH terms

  • Animals
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / physiology*
  • Dogs
  • Drinking Behavior / drug effects*
  • Fasting
  • Feeding Behavior / drug effects*
  • Food Deprivation
  • Injections, Intraventricular
  • Insulin / pharmacology
  • Naloxone / pharmacology
  • Neuropeptide Y / pharmacology
  • Sincalide / administration & dosage
  • Sincalide / pharmacology*

Substances

  • Insulin
  • Neuropeptide Y
  • Naloxone
  • Sincalide